NextCure (NXTC) Stock Highlights

1.19 | -7.75%

2024-11-23 06:29:51

NextCure Inc is a clinical-stage biopharmaceutical company committed to discovering and developing immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. It is focused on understanding biological pathways, the interactions of cells and the role each interaction plays in an immune response. The companys product candidate, NC318, is an immunomedicine against an immunomodulatory receptor called Siglec-15, or S15.

Statistics

Range Today

1.16 1.3

Volume Today 163K

Range 1 Year

1.03 2.57

Volume 1 Year 30.84M

Range 3 Year

0.98 6.63

Volume 3 Year 90.25M

Range 10 Year

0.98 109

Volume 10 Year 309.22M

Highlights

Market Capitalization 36.09M (micro)

Floating Shares 18.64M

Current Price 1.19

Price To Earnings -0.62

Price To Book 0.31

Earnings Per Share -2.19

Payout Ratio 0%

Performance

Latest -7.75%

1 Month -11.19%

3 Months -26.99%

6 Months -29.17%

1 Year -6.3%

3 Years -79.48%

5 Years -96.75%

10 Years -92.35%

Benchmarks

Market Capitalization

302 / 368

Gross Profits

201 / 278

Total Revenue

0 / 300

Total Rank

41 / 368

Free Cashflow

172 / 352

Performance 5 years

335 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.